NCT06136013

Brief Summary

Many investigations have been done to determine the exercise that can elicit the greatest benefits on glycemic control and metabolic health, with findings suggesting that incorporation of higher intensity and longer duration of exercise prescribed may eliminate much of the "non-response" observed following exercise training. Even with the incorporation of higher intensity exercise into interventions aimed at improving glycemic control in individuals with type 2 diabetes mellitus (T2DM), the investigators and others continue to have mixed results, with not all individuals with T2DM obtaining benefits in insulin sensitivity and glycemic control to a given exercise training program. Many of the metabolic processes involved in glucose homeostasis, such as insulin production and sensitivity, undergo daily circadian rhythms, controlled by cellular clock machinery located both centrally and peripherally (i.e. skeletal muscle). However, in adults with T2DM, these diurnal rhythms are impaired, with reduced insulin sensitivity in the morning, which is thought to contribute to the fasting hyperglycemia (i.e., "dawn phenomenon") observed in these individuals. Exercise may be a non-photic cue that can amplify or alter these metabolic rhythms. It has been suggested that skeletal muscle metabolic inflexibility in metabolic disorders such as overweight/obesity and T2DM is associated with reduced mitochondrial fatty acid oxidative capacity. It has been demonstrated that exercise can increase mitochondrial oxidative capacity by remodeling mitochondrial morphology and dynamics. It is unknown if potential differences in metabolic flexibility can be found in response to exercise at different times of the day. Most of the experimental evidence originates from animal models with only 3 studies performed in humans with T2DM, which displayed conflicting results. To overcome the shortcomings in the literature, the main objective of this research project is to assess the effects of performing exercise at different times of the day on glycemic control and related outcomes on the inter-individual response variability in glycemic control and related metabolic health parameters in two distinct populations: 1) individuals with T2DM on the most common mono-hyperglycemic drug therapy (i.e., metformin); and 2) age-matched sedentary overweight/obese individuals, where glycemic control is known to deteriorate, hence increasing the risk of developing insulin resistance and T2DM.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
34

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 26, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

6 months

First QC Date

July 26, 2023

Last Update Submit

November 15, 2023

Conditions

Keywords

ExerciseDiabetes Mellitus Type 2Glycemic ControlInter-individual variabilityAgingObesity

Outcome Measures

Primary Outcomes (1)

  • Changes in 24-hour area under cover (AUC) glucose from baseline to 1, 2, and 3 months

    Assess differences in 24-hour area under cover (AUC) glucose at different exercise times (i.e. morning, afternoon and evening) separately for individuals with T2DM and age-matched overweight/obese older adults.

    3 months

Secondary Outcomes (12)

  • Changes in body mass index (BMI) from baseline to 1, 2, and 3 months

    3 months

  • Changes in bone mineral density from baseline to 1, 2, and 3 months

    3 months

  • Changes in fat and lean body mass from baseline to 1, 2, and 3 months

    3 months

  • Changes in resting metabolic rate (RMR) from baseline to 1, 2, and 3 months

    3 months

  • Changes in respiratory quotient from baseline to 1, 2, and 3 months

    3 months

  • +7 more secondary outcomes

Study Arms (3)

Morning HIIT 30-min following breakfast between 9:00 to 10:00 am.

EXPERIMENTAL

The exercise prescription will be standardized according to body weight and based on physical activity guidelines to achieve a weekly target of 10 kcal/kg. The duration of the exercise sessions will be based on the weekly target for energy expenditure, considering weight and individual VO2peak and will be updated at the beginning of each intervention block.

Behavioral: HIIT

Afternoon HIIT 30-min following lunch between 2:00 to 3:00 pm.

EXPERIMENTAL

The exercise prescription will be standardized according to body weight and based on physical activity guidelines to achieve a weekly target of 10 kcal/kg. The duration of the exercise sessions will be based on the weekly target for energy expenditure, considering weight and individual VO2peak and will be updated at the beginning of each intervention block.

Behavioral: HIIT

Evening HIIT 30-min following dinner between 7:00 to 8:00 pm.

EXPERIMENTAL

The exercise prescription will be standardized according to body weight and based on physical activity guidelines to achieve a weekly target of 10 kcal/kg. The duration of the exercise sessions will be based on the weekly target for energy expenditure, considering weight and individual VO2peak and will be updated at the beginning of each intervention block.

Behavioral: HIIT

Interventions

HIITBEHAVIORAL

1 minute of exercise at 90% of their PPO, followed by a 1-minute rest at 40-60% of their peak power output using a cycle ergometer.

Afternoon HIIT 30-min following lunch between 2:00 to 3:00 pm.Evening HIIT 30-min following dinner between 7:00 to 8:00 pm.Morning HIIT 30-min following breakfast between 9:00 to 10:00 am.

Eligibility Criteria

Age55 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • previous diagnosis of T2DM
  • currently taking metformin (Group 1 only);
  • Adults aged 55 to 75 years
  • Physically inactive people (i.e. with less than 20 minutes per day of exercise, maximum 3 days per week)

You may not qualify if:

  • Use of exogenous insulin and taking any other antihyperglycemic medication beyond metformin
  • having major micro- or macro-vascular complications from T2DM
  • History of cardiovascular incidents
  • People with motor limitations (musculoskeletal or neurological) that limit the practice of physical exercise
  • inability to provide informed consent
  • BMI ≥25 without diagnosis of T2DM
  • Adults aged 55 to 75 years
  • Physically inactive people (i.e. with less than 20 minutes per day of exercise, maximum 3 days per week)
  • History of cardiovascular incidents
  • People with motor limitations (musculoskeletal or neurological) that limit the practice of physical exercise
  • inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculdade de Motricidade Humana

Cruz Quebrada, Oeiras, 1409-002, Portugal

Location

Related Publications (1)

  • Magalhaes JP, Oliveira EC, Hetherington-Rauth M, Jesus F, Rodrigues MC, Raposo JF, Ribeiro RT, Caetano C, Sardinha LB. The Ex-Timing trial: evaluating morning, afternoon, and evening exercise on the circadian clock in individuals with type 2 diabetes and overweight/obesity-a randomized crossover study protocol. Trials. 2024 Aug 6;25(1):526. doi: 10.1186/s13063-024-08335-y.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor ActivityObesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehaviorOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • João B Magalhães, PhD

    Faculdade de Motricidade Humana - Universidade de Lisboa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

João B Magalhães, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: This project will consist of a randomized cross-over exercise intervention involving 2 groups: Group 1, individuals with T2DM; Group 2, age-matched older adults with overweight/obesity. Each study will consist of 3, 2-week blocks of 3 days per week of supervised post-prandial exercise using high-intensity interval training (HIIT). Between each training block, a 2-week washout period, where participants avoid structured exercise, will take place. This has been shown to be enough time to eliminate any exercise effects on insulin sensitivity and glycemic control. The cross-over groups are the following: 1. morning HIIT. 2. afternoon HIIT. 3. evening HIIT. Each participant will serve as their own control, helping to account for the biological variability within the individual, as well as their individual chronotype, such as sleep/wake cycles. Participants will be randomly selected to a block order.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 26, 2023

First Posted

November 18, 2023

Study Start

January 1, 2024

Primary Completion

July 1, 2024

Study Completion

December 1, 2024

Last Updated

November 18, 2023

Record last verified: 2023-11

Locations